AI-generated summary
The authors studied whether fluorescent blue light at about 417 nm, at fluences of 10, 30, and 45 J/cm2, causes DNA damage in human dermal fibroblasts, measuring cyclobutane pyrimidine dimers and 6-4 photoproducts. They report that blue light exposure did not produce detectable DNA damage, unlike ultraviolet light. The authors state this supports the safety of fluorescent blue light therapy, while calling for further clinical investigation.
- Who or what was studied
- Human dermal fibroblasts (cells grown in culture)
- Wavelengths
- 417 nm
- Limits stated in the abstract
- The abstract describes an in vitro cell study and states that continued clinical investigation is needed to understand the skin safety profile.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 400-500 nm
- Energy density (fluence)
- 45 J/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Light-emitting diode, Near-infrared, Ultraviolet. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.